Krystal Biotech (KRYS) Change in Taxes (2024 - 2026)

Krystal Biotech has reported Change in Taxes for 3 years, with the latest figure at $4.7 million in Q2 2026.

• Change in Taxes for Q2 2026 came in at $4.7 million, up 232.17% year-over-year; the trailing twelve-month figure through Jun 2026 was $12.7 million (changed N/A YoY), and the FY2025 annual result was $12.4 million, up 666.17% from the prior year.
• Change in Taxes improved to $4.7 million in Q2 2026, from -$3.4 million in the prior quarter.
• Over five years, Change in Taxes peaked at $9.2 million in Q3 2025 and troughed at -$3.4 million in Q1 2026.
• A 3-year average of $2.1 million and a median of $1.4 million in 2025 frame the typical range for Change in Taxes.
• The largest YoY upside for Change in Taxes was 232.17% in 2026 against a maximum downside of 636.32% in 2026.
• A 3-year view of Change in Taxes shows it stood at $971000.0 in 2024, then jumped by 135.43% to $2.3 million in 2025, then surged by 104.16% to $4.7 million in 2026.
• Per Business Quant data, the three most recent Change in Taxes figures were $4.7 million in Q2 2026, -$3.4 million in Q1 2026, and $2.3 million in Q4 2025.